Two Sigma Investments’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-521,965
| Closed | -$21M | – | 5049 |
|
|
2026
Q1 | $21M | Sell |
521,965
-40,396
| -7% | -$871K | 0.02% | 916 |
|
|
2025
Q4 | $14.1M | Buy |
562,361
+310,293
| +123% | +$7.28M | 0.02% | 910 |
|
|
2025
Q3 | $5.7M | Sell |
252,068
-154,845
| -38% | -$3.61M | 0.01% | 1344 |
|
|
2025
Q2 | $7.04M | Buy |
406,913
+144,009
| +55% | +$2.67M | 0.01% | 1029 |
|
|
2025
Q1 | $5.75M | Buy |
+262,904
| New | +$7.26M | 0.01% | 1047 |
|
|
2024
Q4 | – | Sell |
-58,783
| Closed | -$1.7M | – | 3191 |
|
|
2024
Q3 | $1.7M | Buy |
58,783
+31,237
| +113% | +$1.16M | ﹤0.01% | 1775 |
|
|
2024
Q2 | $1.06M | Buy |
+27,546
| New | +$1.25M | ﹤0.01% | 1954 |
|
|
2022
Q4 | – | Sell |
-113,472
| Closed | -$7.75M | – | 2786 |
|
|
2022
Q3 | $7.75M | Buy |
+113,472
| New | +$6.71M | 0.03% | 585 |
|
|
2021
Q4 | – | Sell |
-362,204
| Closed | -$11.9M | – | 4243 |
|
|
2021
Q3 | $11.9M | Sell |
362,204
-112,834
| -24% | -$6.34M | 0.03% | 687 |
|
|
2021
Q2 | $30M | Buy |
475,038
+90,307
| +23% | +$4.66M | 0.07% | 347 |
|
|
2021
Q1 | $16.5M | Buy |
384,731
+179,991
| +88% | +$8.52M | 0.04% | 504 |
|
|
2020
Q4 | $11.7M | Sell |
204,740
-106,240
| -34% | -$4.49M | 0.03% | 546 |
|
|
2020
Q3 | $9.38M | Sell |
310,980
-238,558
| -43% | -$7.13M | 0.03% | 527 |
|
|
2020
Q2 | $17.9M | Buy |
549,538
+118,199
| +27% | +$3.8M | 0.09% | 241 |
|
|
2020
Q1 | $11.6M | Buy |
431,339
+214,562
| +99% | +$7.62M | 0.09% | 223 |
|
|
2019
Q4 | $6.64M | Buy |
216,777
+71,464
| +49% | +$1.98M | 0.02% | 799 |
|
|
2019
Q3 | $3.5M | Buy |
+145,313
| New | +$4M | 0.01% | 1062 |
|
Other funds holding APLS
Two Sigma Investments's APLS Position: Q2 2026 in Review
Two Sigma Investments sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 521,965 shares — an estimated $21M sold.
Two Sigma Investments first reported a position in APLS in Q3 2019 and held it in 17 quarters. The position peaked at $30M in Q2 2021. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- Two Sigma Investments reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Two Sigma Investments sold 521,965 Apellis Pharmaceuticals shares in Q2 2026, an estimated $21M.
- Two Sigma Investments first reported a position in Apellis Pharmaceuticals in Q3 2019 and held it in 17 quarters.
- Two Sigma Investments's Apellis Pharmaceuticals position peaked at $30M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.